Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (Scientific Reports, (2019), 9, 1, (7013), 10.1038/s41598-019-43458-2)

Arvid Rongve; Aree Witoelar; Agustín Ruiz; Lavinia Athanasiu; Carla Abdelnour; Jordi Clarimon; Stefanie Heilmann-Heimbach; Isabel Hernández; Sonia Moreno-Grau; Itziar de Rojas; Estrella Morenas-Rodríguez; Tormod Fladby; Sigrid B. Sando; Geir Bråthen; Frédéric Blanc; Olivier Bousiges; Afina W. Lemstra; Inger van Steenoven; Elisabet Londos; Ina S. Almdahl; Lene Pålhaugen; Jon A. Eriksen; Srdjan Djurovic; Eystein Stordal; Ingvild Saltvedt; Ingun D. Ulstein; Francesco Bettella; Rahul S. Desikan; Ane-Victoria Idland; Mathias Toft; Lasse Pihlstrøm; Jon Snaedal; Lluís Tárraga; Mercè Boada; Alberto Lleó; Hreinn Stefánsson; K. ri Stefánsson; Alfredo Ramírez; Dag Aarsland; Ole A. Andreassen

doi:https://doi.org/10.1038/s41598-019-51827-0

Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (Scientific Reports, (2019), 9, 1, (7013), 10.1038/s41598-019-43458-2)

Arvid Rongve, Aree Witoelar, Agustín Ruiz, Lavinia Athanasiu, Carla Abdelnour, Jordi Clarimon, Stefanie Heilmann-Heimbach, Isabel Hernández, Sonia Moreno-Grau, Itziar de Rojas, Estrella Morenas-Rodríguez, Tormod Fladby, Sigrid B. Sando, Geir Bråthen, Frédéric Blanc, Olivier Bousiges, Afina W. Lemstra, Inger van Steenoven, Elisabet Londos, Ina S. AlmdahlLene Pålhaugen, Jon A. Eriksen, Srdjan Djurovic, Eystein Stordal, Ingvild Saltvedt, Ingun D. Ulstein, Francesco Bettella, Rahul S. Desikan, Ane-Victoria Idland, Mathias Toft, Lasse Pihlstrøm, Jon Snaedal, Lluís Tárraga, Mercè Boada, Alberto Lleó, Hreinn Stefánsson, K. ri Stefánsson, Alfredo Ramírez, Dag Aarsland, Ole A. Andreassen

Research output: Contribution to journal › Erratum/Corrigendum › Academic › peer-review

2 Citations (Scopus)

Abstract

“The authors would like to thank the Norwegian Dementia Genetics Network (DemGene), the European DLB Consortium (E-DLB), Dementia Genetics Spanish Consortium (DEGESCO) and Genomic Research at Fundació ACE (GR@ACE) Consortium. Fundació ACE would like to thank patients and controls who participated in this project. We are indebted to private donors for their support of Fundació ACE research programs. Fundació ACE collaborates with the Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain) and is one of the participating centers of the Dementia Genetics Spanish Consortium (DEGESCO). The study was founded by the Research Council of Norway, Norwegian Regional Health Authorities and Norwegian Health Association and 237250/EU/JPND (APGeM). The Cohort 2 results were generated with the assistance of financial support of grants PI13/02434 and PI16/01861. Acción Estratégica en Salud, integrated in the Spanish National R + D + I Plan and financed by ISCIII (Instituto de Salud Carlos III)-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER- “Una manera de Hacer Europa”). GR@ACE project has been funded by Fundación bancaria “La Caixa”, Grifols SA, Fundació ACE. The funding sources did not in any way affect the results or presentation of the results.” should read: “The authors would like to thank the Norwegian Dementia Genetics Network (DemGene), the European DLB Consortium (E-DLB), Dementia Genetics Spanish Consortium (DEGESCO) and Genomic Research at Fundació ACE (GR@ACE) Consortium. Fundació ACE would like to thank patients and controls who participated in this project. We are indebted to private donors for their support of Fundació ACE research programs. Fundació ACE collaborates with the Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain) and is one of the participating centers of the Dementia Genetics Spanish Consortium (DEGESCO). The study was founded by the Research Council of Norway, Norwegian Regional Health Authorities and Norwegian Health Association and 237250/EU/JPND (APGeM). The Cohort 2 results were generated with the assistance of financial support of grants PI13/02434 and PI16/01861. Acción Estratégica en Salud, integrated in the Spanish National R + D + I Plan and financed by ISCIII (Instituto de Salud Carlos III)-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER- “Una manera de Hacer Europa”). GR@ACE project has been funded by Fundación bancaria “La Caixa”, Grifols SA, Fundació ACE. The funding sources did not in any way affect the results or presentation of the results. This paper represents independent research partly funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care”.

Original language	English
Article number	15168
Journal	Scientific reports
Volume	9
Issue number	1
DOIs	https://doi.org/10.1038/s41598-019-51827-0
Publication status	Published - 1 Dec 2019

Access to Document

https://doi.org/10.1038/s41598-019-51827-0

Cite this

Rongve, A., Witoelar, A., Ruiz, A., Athanasiu, L., Abdelnour, C., Clarimon, J., Heilmann-Heimbach, S., Hernández, I., Moreno-Grau, S., de Rojas, I., Morenas-Rodríguez, E., Fladby, T., Sando, S. B., Bråthen, G., Blanc, F., Bousiges, O., Lemstra, A. W., van Steenoven, I., Londos, E., ... Andreassen, O. A. (2019). Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (Scientific Reports, (2019), 9, 1, (7013), 10.1038/s41598-019-43458-2). Scientific reports, 9(1), Article 15168. https://doi.org/10.1038/s41598-019-51827-0

@article{003621f289fa46a383e300612c21bfeb,

title = "Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (Scientific Reports, (2019), 9, 1, (7013), 10.1038/s41598-019-43458-2)",

abstract = "“The authors would like to thank the Norwegian Dementia Genetics Network (DemGene), the European DLB Consortium (E-DLB), Dementia Genetics Spanish Consortium (DEGESCO) and Genomic Research at Fundaci{\'o} ACE (GR@ACE) Consortium. Fundaci{\'o} ACE would like to thank patients and controls who participated in this project. We are indebted to private donors for their support of Fundaci{\'o} ACE research programs. Fundaci{\'o} ACE collaborates with the Centro de Investigaci{\'o}n Biom{\'e}dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain) and is one of the participating centers of the Dementia Genetics Spanish Consortium (DEGESCO). The study was founded by the Research Council of Norway, Norwegian Regional Health Authorities and Norwegian Health Association and 237250/EU/JPND (APGeM). The Cohort 2 results were generated with the assistance of financial support of grants PI13/02434 and PI16/01861. Acci{\'o}n Estrat{\'e}gica en Salud, integrated in the Spanish National R + D + I Plan and financed by ISCIII (Instituto de Salud Carlos III)-Subdirecci{\'o}n General de Evaluaci{\'o}n and the Fondo Europeo de Desarrollo Regional (FEDER- “Una manera de Hacer Europa”). GR@ACE project has been funded by Fundaci{\'o}n bancaria “La Caixa”, Grifols SA, Fundaci{\'o} ACE. The funding sources did not in any way affect the results or presentation of the results.” should read: “The authors would like to thank the Norwegian Dementia Genetics Network (DemGene), the European DLB Consortium (E-DLB), Dementia Genetics Spanish Consortium (DEGESCO) and Genomic Research at Fundaci{\'o} ACE (GR@ACE) Consortium. Fundaci{\'o} ACE would like to thank patients and controls who participated in this project. We are indebted to private donors for their support of Fundaci{\'o} ACE research programs. Fundaci{\'o} ACE collaborates with the Centro de Investigaci{\'o}n Biom{\'e}dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain) and is one of the participating centers of the Dementia Genetics Spanish Consortium (DEGESCO). The study was founded by the Research Council of Norway, Norwegian Regional Health Authorities and Norwegian Health Association and 237250/EU/JPND (APGeM). The Cohort 2 results were generated with the assistance of financial support of grants PI13/02434 and PI16/01861. Acci{\'o}n Estrat{\'e}gica en Salud, integrated in the Spanish National R + D + I Plan and financed by ISCIII (Instituto de Salud Carlos III)-Subdirecci{\'o}n General de Evaluaci{\'o}n and the Fondo Europeo de Desarrollo Regional (FEDER- “Una manera de Hacer Europa”). GR@ACE project has been funded by Fundaci{\'o}n bancaria “La Caixa”, Grifols SA, Fundaci{\'o} ACE. The funding sources did not in any way affect the results or presentation of the results. This paper represents independent research partly funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King{\textquoteright}s College London. The views expressed are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care”.",

author = "Arvid Rongve and Aree Witoelar and Agust{\'i}n Ruiz and Lavinia Athanasiu and Carla Abdelnour and Jordi Clarimon and Stefanie Heilmann-Heimbach and Isabel Hern{\'a}ndez and Sonia Moreno-Grau and {de Rojas}, Itziar and Estrella Morenas-Rodr{\'i}guez and Tormod Fladby and Sando, {Sigrid B.} and Geir Br{\aa}then and Fr{\'e}d{\'e}ric Blanc and Olivier Bousiges and Lemstra, {Afina W.} and {van Steenoven}, Inger and Elisabet Londos and Almdahl, {Ina S.} and Lene P{\aa}lhaugen and Eriksen, {Jon A.} and Srdjan Djurovic and Eystein Stordal and Ingvild Saltvedt and Ulstein, {Ingun D.} and Francesco Bettella and Desikan, {Rahul S.} and Ane-Victoria Idland and Mathias Toft and Lasse Pihlstr{\o}m and Jon Snaedal and Llu{\'i}s T{\'a}rraga and Merc{\`e} Boada and Alberto Lle{\'o} and Hreinn Stef{\'a}nsson and Stef{\'a}nsson, {K. ri} and Alfredo Ram{\'i}rez and Dag Aarsland and Andreassen, {Ole A.}",

year = "2019",

month = dec,

day = "1",

doi = "https://doi.org/10.1038/s41598-019-51827-0",

language = "English",

volume = "9",

journal = "Scientific reports",

issn = "2045-2322",

publisher = "Springer Nature",

number = "1",

}

Rongve, A, Witoelar, A, Ruiz, A, Athanasiu, L, Abdelnour, C, Clarimon, J, Heilmann-Heimbach, S, Hernández, I, Moreno-Grau, S, de Rojas, I, Morenas-Rodríguez, E, Fladby, T, Sando, SB, Bråthen, G, Blanc, F, Bousiges, O, Lemstra, AW, van Steenoven, I, Londos, E, Almdahl, IS, Pålhaugen, L, Eriksen, JA, Djurovic, S, Stordal, E, Saltvedt, I, Ulstein, ID, Bettella, F, Desikan, RS, Idland, A-V, Toft, M, Pihlstrøm, L, Snaedal, J, Tárraga, L, Boada, M, Lleó, A, Stefánsson, H, Stefánsson, KR, Ramírez, A, Aarsland, D & Andreassen, OA 2019, 'Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (Scientific Reports, (2019), 9, 1, (7013), 10.1038/s41598-019-43458-2)', Scientific reports, vol. 9, no. 1, 15168. https://doi.org/10.1038/s41598-019-51827-0

Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (Scientific Reports, (2019), 9, 1, (7013), 10.1038/s41598-019-43458-2). / Rongve, Arvid; Witoelar, Aree; Ruiz, Agustín et al.
In: Scientific reports, Vol. 9, No. 1, 15168, 01.12.2019.

Research output: Contribution to journal › Erratum/Corrigendum › Academic › peer-review

TY - JOUR

T1 - Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (Scientific Reports, (2019), 9, 1, (7013), 10.1038/s41598-019-43458-2)

AU - Rongve, Arvid

AU - Witoelar, Aree

AU - Ruiz, Agustín

AU - Athanasiu, Lavinia

AU - Abdelnour, Carla

AU - Clarimon, Jordi

AU - Heilmann-Heimbach, Stefanie

AU - Hernández, Isabel

AU - Moreno-Grau, Sonia

AU - de Rojas, Itziar

AU - Morenas-Rodríguez, Estrella

AU - Fladby, Tormod

AU - Sando, Sigrid B.

AU - Bråthen, Geir

AU - Blanc, Frédéric

AU - Bousiges, Olivier

AU - Lemstra, Afina W.

AU - van Steenoven, Inger

AU - Londos, Elisabet

AU - Almdahl, Ina S.

AU - Pålhaugen, Lene

AU - Eriksen, Jon A.

AU - Djurovic, Srdjan

AU - Stordal, Eystein

AU - Saltvedt, Ingvild

AU - Ulstein, Ingun D.

AU - Bettella, Francesco

AU - Desikan, Rahul S.

AU - Idland, Ane-Victoria

AU - Toft, Mathias

AU - Pihlstrøm, Lasse

AU - Snaedal, Jon

AU - Tárraga, Lluís

AU - Boada, Mercè

AU - Lleó, Alberto

AU - Stefánsson, Hreinn

AU - Stefánsson, K. ri

AU - Ramírez, Alfredo

AU - Aarsland, Dag

AU - Andreassen, Ole A.

PY - 2019/12/1

Y1 - 2019/12/1

N2 - “The authors would like to thank the Norwegian Dementia Genetics Network (DemGene), the European DLB Consortium (E-DLB), Dementia Genetics Spanish Consortium (DEGESCO) and Genomic Research at Fundació ACE (GR@ACE) Consortium. Fundació ACE would like to thank patients and controls who participated in this project. We are indebted to private donors for their support of Fundació ACE research programs. Fundació ACE collaborates with the Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain) and is one of the participating centers of the Dementia Genetics Spanish Consortium (DEGESCO). The study was founded by the Research Council of Norway, Norwegian Regional Health Authorities and Norwegian Health Association and 237250/EU/JPND (APGeM). The Cohort 2 results were generated with the assistance of financial support of grants PI13/02434 and PI16/01861. Acción Estratégica en Salud, integrated in the Spanish National R + D + I Plan and financed by ISCIII (Instituto de Salud Carlos III)-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER- “Una manera de Hacer Europa”). GR@ACE project has been funded by Fundación bancaria “La Caixa”, Grifols SA, Fundació ACE. The funding sources did not in any way affect the results or presentation of the results.” should read: “The authors would like to thank the Norwegian Dementia Genetics Network (DemGene), the European DLB Consortium (E-DLB), Dementia Genetics Spanish Consortium (DEGESCO) and Genomic Research at Fundació ACE (GR@ACE) Consortium. Fundació ACE would like to thank patients and controls who participated in this project. We are indebted to private donors for their support of Fundació ACE research programs. Fundació ACE collaborates with the Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain) and is one of the participating centers of the Dementia Genetics Spanish Consortium (DEGESCO). The study was founded by the Research Council of Norway, Norwegian Regional Health Authorities and Norwegian Health Association and 237250/EU/JPND (APGeM). The Cohort 2 results were generated with the assistance of financial support of grants PI13/02434 and PI16/01861. Acción Estratégica en Salud, integrated in the Spanish National R + D + I Plan and financed by ISCIII (Instituto de Salud Carlos III)-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER- “Una manera de Hacer Europa”). GR@ACE project has been funded by Fundación bancaria “La Caixa”, Grifols SA, Fundació ACE. The funding sources did not in any way affect the results or presentation of the results. This paper represents independent research partly funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care”.

AB - “The authors would like to thank the Norwegian Dementia Genetics Network (DemGene), the European DLB Consortium (E-DLB), Dementia Genetics Spanish Consortium (DEGESCO) and Genomic Research at Fundació ACE (GR@ACE) Consortium. Fundació ACE would like to thank patients and controls who participated in this project. We are indebted to private donors for their support of Fundació ACE research programs. Fundació ACE collaborates with the Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain) and is one of the participating centers of the Dementia Genetics Spanish Consortium (DEGESCO). The study was founded by the Research Council of Norway, Norwegian Regional Health Authorities and Norwegian Health Association and 237250/EU/JPND (APGeM). The Cohort 2 results were generated with the assistance of financial support of grants PI13/02434 and PI16/01861. Acción Estratégica en Salud, integrated in the Spanish National R + D + I Plan and financed by ISCIII (Instituto de Salud Carlos III)-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER- “Una manera de Hacer Europa”). GR@ACE project has been funded by Fundación bancaria “La Caixa”, Grifols SA, Fundació ACE. The funding sources did not in any way affect the results or presentation of the results.” should read: “The authors would like to thank the Norwegian Dementia Genetics Network (DemGene), the European DLB Consortium (E-DLB), Dementia Genetics Spanish Consortium (DEGESCO) and Genomic Research at Fundació ACE (GR@ACE) Consortium. Fundació ACE would like to thank patients and controls who participated in this project. We are indebted to private donors for their support of Fundació ACE research programs. Fundació ACE collaborates with the Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain) and is one of the participating centers of the Dementia Genetics Spanish Consortium (DEGESCO). The study was founded by the Research Council of Norway, Norwegian Regional Health Authorities and Norwegian Health Association and 237250/EU/JPND (APGeM). The Cohort 2 results were generated with the assistance of financial support of grants PI13/02434 and PI16/01861. Acción Estratégica en Salud, integrated in the Spanish National R + D + I Plan and financed by ISCIII (Instituto de Salud Carlos III)-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER- “Una manera de Hacer Europa”). GR@ACE project has been funded by Fundación bancaria “La Caixa”, Grifols SA, Fundació ACE. The funding sources did not in any way affect the results or presentation of the results. This paper represents independent research partly funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care”.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073476699&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31619746

U2 - https://doi.org/10.1038/s41598-019-51827-0

DO - https://doi.org/10.1038/s41598-019-51827-0

M3 - Erratum/Corrigendum

C2 - 31619746

SN - 2045-2322

VL - 9

JO - Scientific reports

JF - Scientific reports

IS - 1

M1 - 15168

ER -

Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (Scientific Reports, (2019), 9, 1, (7013), 10.1038/s41598-019-43458-2)

Abstract

Access to Document

Other files and links

Cite this